Suchergebnisse - (Person:"Wei, Xiang")

PubPharm (47)

41

Prognostic value of Ezrin in solid tumors : a meta-analysis of the literature

enthalten in: PloS one | 2013

von Han, K. | Qi, W. | Gan, Z. | +3

42

Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer : a systematic review and meta-analysis

enthalten in: Lung | 2012

von Qi, W. | Tang, L. | He, A. | +3

CommentIn: Lung. 2012 Dec;190(6):591-2; author reply 592. - PMID 23081731

43

Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer : a systematic review and meta-analysis

enthalten in: Journal of cancer research and clinical oncology | 2012

von Qi, W. | Tang, L. | He, A. | +2

44

Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer

enthalten in: Cancer chemotherapy and pharmacology | 2012

von Qi, W. | Shen, Z. | Yao, Y.

45

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer : a systematic review and meta-analysis

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2012

von Qi, W. | Shen, Z. | Lin, F. | +5

46

Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer : a meta-analysis of four randomized controlled trials

enthalten in: Journal of cancer research and clinical oncology | 2011

von Qi, W. | Shen, Z. | Yao, Y.

47

The role of vandetanib in the second-line treatment for advanced non-small-cell-lung cancer : a meta-analysis of four randomized controlled trials

enthalten in: Lung | 2011

von Qi, W. | Tang, L. | He, A. | +2